6565 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1978)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M. N.; Evans, K. L.; Prockop, S.; Scaradavou, A.; Kernan, N. A.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Integrated genetic profiling of JAK2 wildtype chronic-phase myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; Patel, J. P.; Knapp, K. M.; Patel, M.; Greenbowe, J. R.; Young, L. E.; He, J.; Wang, K.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Multiple copies of MLL is the most commonly detected cytogenetic abnormality in newly diagnosed multiple myeloma and may modify disease risk
    Meeting Abstract

    Landry, C.; Londono, D.; Devlin, S. M.; Lesokhin, A.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; Jhanwar, S. C.; Giralt, S. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed multiple myeloma and high-risk cytogenetics permits long-lasting remissions in the absence of graft-versus-host disease
    Meeting Abstract

    Koehne, G.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S.
    Blood (2013)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions
    Meeting Abstract

    Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute GVHD without increased toxicity in double-unit cord blood transplantation (CBT) recipients
    Meeting Abstract

    Harnicar, S. J.; Ponce, D. M.; Gregornik, D.; Mathew, S.; Evans, K. L.; Zheng, J.; Devlin, S.; Pozotrigo, M.; Scaradavou, A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save